B
Bruce Neal
Researcher at The George Institute for Global Health
Publications - 620
Citations - 109123
Bruce Neal is an academic researcher from The George Institute for Global Health. The author has contributed to research in topics: Population & Blood pressure. The author has an hindex of 108, co-authored 561 publications receiving 87213 citations. Previous affiliations of Bruce Neal include National Institutes of Health & University of the Western Cape.
Papers
More filters
Journal Article
Methodological Trends in Studies Based on Verbal Autopsies before and after Published guidelines/Tendances Methodologiques Des Etudes Reposant Sur Des Autopsies Verbales Avant et Apres la Publication De directives/Tendencias Metodologicas De Los Estudios Basados En Autopsias Verbales Antes Y Despues De la Publicacion De Directrices Al Respecto
TL;DR: In the early 1990s, a series of expert meetings that led to the publication of several reports (4,5,7,8) in which key design features for studies based on verbal autopsies were recommended were recommended.
Journal ArticleDOI
Low dietary sodium in heart failure: a need for scientific rigour
Min Jun,Bruce Neal +1 more
TL;DR: A key challenge for these guidelines has been the absence of definitive evidence that reduced dietary sodium translates into lower risks of ‘hard’ clinical outcomes such as stroke and heart attack.
Journal ArticleDOI
Wellbeing at work among kitchen workers during organic food conversion in Danish public kitchens: a longitudinal survey
Nina Nørgaard Sørensen,Hanne Løje,Inge Tetens,Jason H Y Wu,Bruce Neal,Bruce Neal,Bruce Neal,Anne Dahl Lassen +7 more
TL;DR: A significant increase in motivation to work among kitchen staff was observed with no substantive changes in physical or psychological wellbeing at work identified and the results support the Danish Organic Action Plan 2020 and initiatives of similar kind.
Journal ArticleDOI
The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: analysis of the credence trial
Clare Arnott,Clare Arnott,Jing-Wei Li,Jing-Wei Li,Christopher P. Cannon,Christopher P. Cannon,Brendon L. Neuen,Brendon L. Neuen,Hiddo J.L. Heerspink,Hiddo J.L. Heerspink,Bruce Neal,Bruce Neal,David M. Charytan,David M. Charytan,Rajiv Agarwal,Rajiv Agarwal,George Bakris,George Bakris,Dick De Zeeuw,Dick De Zeeuw,Tom Greene,Tom Greene,Adeera Levin,Adeera Levin,C. Pollock,C. Pollock,Tara I. Chang,Tara I. Chang,Norman Rosenthal,Norman Rosenthal,Hong Zhang,Hong Zhang,Bernard Zinman,Bernard Zinman,Vlado Perkovic,Vlado Perkovic,Meg Jardine,Meg Jardine,Kenneth Mahaffey,Kenneth Mahaffey +39 more
TL;DR: Individuals with type 2 diabetes mellitus and chronic kidney disease are at high risk for hospitalized heart failure and these events are reduced by canagliflozin (CANA), and the effect of CANA on HHF or cardiovascular death differs by key.